{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:59:03Z","timestamp":1774612743038,"version":"3.50.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To provide a current review of recent publications with regards to intracranial hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Attempts were made to provide pediatric data; however, the recent completion of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) has provided a wealth of data with regards to adult intracranial hypertension.<\/jats:p>\n            <jats:p>The pediatric incidence of intracranial hypertension ranges between 0.63 and 0.71 per 100\u200a000 children. A majority of pediatric cases responded to acetazolamide, with resolution of headache averaging 3.8 weeks. Most patients require less than 1 year of treatment with male sex, older age at diagnosis, primary intracranial hypertension, and lack of headache being predictors of good response. Fluorescein angiography has the highest accuracy in distinguishing true papilledema from pseudopapilledema. The IIHTT found Frisen grade of papilledema was within 1 grade in 92.8% of patients. Monitoring of potassium levels is not required and aplastic anemia was not seen in patients taking acetazolamide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although the newer pediatric studies report incidence rates in pediatric intracranial hypertension are lower than seen in adults, intracranial hypertension is still a concern in pediatrics. There has been a wealth of information with regards to symptomatology, treatment, and outcomes from the IIHTT that will hopefully assist with management in the pediatric population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000689","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:30:51Z","timestamp":1536172251000},"page":"764-774","source":"Crossref","is-referenced-by-count":17,"title":["Intracranial hypertension: a current review"],"prefix":"10.1097","volume":"30","author":[{"given":"Catherine O.","family":"Jordan","sequence":"first","affiliation":[{"name":"Department of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn C.","family":"Aylward","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nationwide Children's Hospital, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/archdischild-2016-312238","article-title":"Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study","volume":"102","author":"Matthews","year":"2017","journal-title":"Arch Dis Child"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2017.04.021","article-title":"Incidence and demographics of pediatric intracranial hypertension","volume":"73","author":"Gillson","year":"2017","journal-title":"Pediatr Neurol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/WNO.0000000000000516","article-title":"Treatment response in pediatric patients with pseudotumor cerebri syndrome","volume":"37","author":"Tovia","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0000000000000114","article-title":"The idiopathic intracranial hypertension treatment trial: design considerations and methods","volume":"34","author":"Friedman","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","article-title":"The idiopathic intracranial hypertension treatment trial: clinical profile at baseline","volume":"71","author":"Wall","year":"2014","journal-title":"JAMA Neurol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/head.13144","article-title":"The Idiopathic Intracranial Hypertension Treatment Trial: a review of the outcomes","volume":"57","author":"Smith","year":"2017","journal-title":"Headache"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","article-title":"Safety and tolerability of acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"36","author":"ten Hove","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2017.08.013","article-title":"Secondary intracranial hypertension in pediatric patients with leukemia","volume":"77","author":"Fernandez-Garcia","year":"2017","journal-title":"Pediatr Neurol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0883073816671855","article-title":"Imaging features of idiopathic intracranial hypertension in children","volume":"32","author":"Hartmann","year":"2017","journal-title":"J Child Neurol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaapos.2017.08.003","article-title":"Diagnostic criteria in pediatric intracranial hypertension","volume":"21","author":"Inger","year":"2017","journal-title":"J AAPOS"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ejpn.2017.08.002","article-title":"Pediatric idiopathic intracranial hypertension: is the fixed threshold value of elevated LP opening pressure set too high?","volume":"21","author":"Gerstl","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.0000000000001896","article-title":"Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension","volume":"85","author":"Wall","year":"2015","journal-title":"Neurology"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clineuro.2017.05.009","article-title":"Predictors of poor visual outcome in patients with idiopathic intracranial hypertension (IIH): an ambispective cohort study","volume":"159","author":"Agarwal","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"R14-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/aos.13664","article-title":"Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension","author":"Hatem","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/01676830.2016.1176051","article-title":"Pediatric and adult vision restoration after optic nerve sheath decompression for idiopathic intracranial hypertension","volume":"35","author":"Bersani","year":"2016","journal-title":"Orbit"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1212\/WNL.0000000000004895","article-title":"Optic nerve head edema among patients presenting to the emergency department","volume":"90","author":"Sachdeva","year":"2018","journal-title":"Neurology"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/01658107.2015.1117498","article-title":"Sixth nerve palsy in paediatric intracranial hypertension","volume":"40","author":"Reid","year":"2016","journal-title":"Neuroophthalmology"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.survophthal.2017.03.008","article-title":"Diplopia is better than no plopia!","volume":"62","author":"Wright","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bjophthalmol-2016-309852","article-title":"Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"101","author":"Wall","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2016.12.017","article-title":"The effect of treatment of idiopathic intracranial hypertension on prevalence of retinal and choroidal folds","volume":"176","author":"Kupersmith","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ophtha.2015.06.003","article-title":"Papilledema outcomes from the optical coherence tomography substudy of the Idiopathic Intracranial Hypertension Treatment Trial","volume":"122","year":"2015","journal-title":"Ophthalmology"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1167\/iovs.14-14960","article-title":"Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability","volume":"55","author":"Auinger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1167\/iovs.14-14961","article-title":"Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features","volume":"55","author":"Auinger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ophtha.2015.12.017","article-title":"Paton's folds\u2019 revisited: peripapillary wrinkles, folds, and creases in papilledema","volume":"123","author":"Sibony","year":"2016","journal-title":"Ophthalmology"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1167\/iovs.16-21089","article-title":"Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"58","author":"Wang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12886-017-0652-7","article-title":"Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension","volume":"17","author":"Aojula","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-017-8532-x","article-title":"Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension","volume":"264","author":"Albrecht","year":"2017","journal-title":"J Neurol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"101.e1","DOI":"10.1016\/j.pediatrneurol.2015.10.022","article-title":"Use of ocular coherence tomography in children with idiopathic intracranial hypertension: a single-center experience","volume":"58","author":"Lee","year":"2016","journal-title":"Pediatr Neurol"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/WNO.0000000000000327","article-title":"Factors affecting visual field outcomes in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"36","author":"Cello","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1167\/iovs.14-14243","article-title":"Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)","volume":"55","author":"Keltner","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1167\/iovs.15-18626","article-title":"Visual field outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)","volume":"57","author":"Wall","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2017.01.004","article-title":"The Longitudinal Idiopathic Intracranial Hypertension Trial: outcomes from months 6-12","volume":"176","author":"Wall","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jemermed.2015.06.090","article-title":"The bedside ultrasound: a rapid way of measuring optic nerve sheath diameter in emergency","volume":"51","author":"Aksoy","year":"2016","journal-title":"J Emerg Med"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/PEC.0000000000001054","article-title":"Ocular ultrasound to detect raised intracranial pressure","volume":"33","author":"Daniel","year":"2017","journal-title":"Pediatr Emerg Care"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"736.e1","DOI":"10.1016\/j.ajem.2018.01.037","article-title":"Real time optic nerve sheath diameter measurement during lumbar puncture","volume":"36","author":"Hassen","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcjd.2015.07.007","article-title":"Optic nerve sheath diameter ultrasonography in pediatric patients with diabetic ketoacidosis","volume":"40","author":"Hansen","year":"2016","journal-title":"Can J Diabetes"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jemermed.2016.04.030","article-title":"In response to: the bedside ultrasound: a rapid way of measuring optic nerve sheath diameter in emergency medicine","volume":"51","author":"Hassen","year":"2016","journal-title":"J Emerg Med"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2015.08.009","article-title":"Bedside optic nerve sheath diameter assessment in the identification of increased intracranial pressure in suspected idiopathic intracranial hypertension","volume":"54","author":"Irazuzta","year":"2016","journal-title":"Pediatr Neurol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12883-017-0964-5","article-title":"Assessment of intracranial pressure with ultrasonographic retrobulbar optic nerve sheath diameter measurement","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Neurol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00415-017-8699-1","article-title":"Ocular ultrasound for monitoring pseudotumor cerebri syndrome","volume":"265","author":"Lochner","year":"2018","journal-title":"J Neurol"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00381-015-3001-2","article-title":"High resolution transbulbar sonography in children with suspicion of increased intracranial pressure","volume":"32","author":"Steinborn","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/tjo.tjo_17_17","article-title":"The diagnostic challenge of evaluating papilledema in the pediatric patient","volume":"7","author":"McCafferty","year":"2017","journal-title":"Taiwan J Ophthalmol"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01658107.2016.1198917","article-title":"Increased prevalence of optic disc drusen after papilloedema from idiopathic intracranial hypertension: on the possible formation of optic disc drusen","volume":"40","author":"Birnbaum","year":"2016","journal-title":"Neuroophthalmology"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.ophtha.2017.06.016","article-title":"Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema","volume":"124","author":"Chang","year":"2017","journal-title":"Ophthalmology"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","article-title":"Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results","volume":"84","author":"Digre","year":"2015","journal-title":"Neurology"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1212\/WNL.0000000000003280","article-title":"Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"87","author":"Bruce","year":"2016","journal-title":"Neurology"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2017.10.020","article-title":"Evidence of diplopia in children's headache drawings helps to differentiate pseudotumor cerebri from migraine","volume":"79","author":"Lee","year":"2018","journal-title":"Pediatr Neurol"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0883073816681352","article-title":"How much cerebrospinal fluid should we remove prior to measuring a closing pressure?","volume":"32","author":"McLaren","year":"2017","journal-title":"J Child Neurol"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajem.2017.01.047","article-title":"Effect of spinal needle characteristics on measurement of spinal canal opening pressure","volume":"35","author":"Bellamkonda","year":"2017","journal-title":"Am J Emerg Med"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/WNO.0000000000000457","article-title":"Temporary lumbar drain as treatment for pediatric fulminant idiopathic intracranial hypertension","volume":"37","author":"Jiramongkolchai","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM199506223322519","article-title":"Levonorgestrel implants and intracranial hypertension","volume":"332","author":"Alder","year":"1995","journal-title":"N Engl J Med"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/01658107.2017.1304425","article-title":"An estimation of the risk of pseudotumor cerebri among users of the levonorgestrel intrauterine device","volume":"41","author":"Valenzuela","year":"2017","journal-title":"Neuroophthalmology"},{"key":"R54-20230918","first-page":"34","article-title":"Reduced suprathreshold odor identification in patients with pseudotumor cerebri: a non-randomized prospective study","volume":"20","author":"Dotan","year":"2018","journal-title":"Isr Med Assoc J"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201812000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:25:51Z","timestamp":1695003951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201812000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000689","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}